CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | Shenouda Maged Chief Financial Officer | Purchase | +79,800 | $4.25 | $339K | 1,000,000 |
| 2026-09-09 | Shenouda Maged Chief Financial Officer | Purchase | +120,200 | $4.20 | $505K | 920,200 |
| 2025-12-15 | Shenouda Maged Chief Financial Officer | Purchase | +11,665 | $4.12 | $48K | 800,000 |
| 2025-12-12 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Appreciation Rights | +828,000 | 828,000 | ||
| 2025-11-05 | Shenouda Maged Chief Financial Officer | Purchase | +500,000 | $2.20 | $1.1M | 788,335 |
| 2025-06-26 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-05-20 | Shenouda Maged Chief Financial Officer | Purchase | +60,000 | $0.52 | $31K | 288,335 |
| 2025-05-19 | Shenouda Maged Chief Financial Officer | Purchase | +90,000 | $0.49 | $44K | 228,335 |
| 2025-05-16 | Shenouda Maged Chief Financial Officer | Purchase | +50,000 | $0.44 | $22K | 138,335 |
| 2024-09-11 | Shenouda Maged Chief Financial Officer | Purchase | +24,120 | $2.95 | $71K | 88,335 |
| 2024-09-10 | Shenouda Maged Chief Financial Officer | Purchase | +21,118 | $2.73 | $58K | 64,215 |
| 2024-09-09 | Shenouda Maged Chief Financial Officer | Purchase | +8,194 | $2.55 | $21K | 43,097 |
| 2024-05-24 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +54,624 | 136,714 | ||
| 2024-05-24 | Shenouda Maged Chief Financial Officer | Other disposition · Stock Option (right to buy) | −54,624 | 82,090 | ||
| 2024-01-31 | Shenouda Maged Chief Financial Officer | Purchase | +6,875 | $4.06 | $28K | 34,903 |
| 2024-01-30 | Shenouda Maged Chief Financial Officer | Purchase | +15,000 | $3.89 | $58K | 28,028 |
| 2024-01-29 | Shenouda Maged Chief Financial Officer | Purchase | +10,800 | $3.65 | $39K | 13,028 |
| 2023-12-15 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +82,090 | 82,090 | ||
| 2023-05-25 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +317,643 | 512,560 | ||
| 2022-12-16 | Shenouda Maged CFO | Other disposition · Stock Option (right to buy) | −200,000 | 0 |
Page 1 of 4 · 68 trades